Your session is about to expire
← Back to Search
Dietary Supplement
Natural Anti-Inflammatory Supplements for Osteoarthritis
Phase 2 & 3
Waitlist Available
Led By Javad Parvizi, MD
Research Sponsored by Physician Recommended Nutriceuticals
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Lequesne's Functional Index score greater than 7 points
Subjects with symptomatic moderate arthritis of the knee defined as per Kellgren-Lawrence grade II or III
Must not have
Subjects with systemic inflammatory conditions such as inflammatory bowel disease, psoriasis, eczema, and others
Subjects taking hormone replacement therapy
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 weeks
Summary
This trial will test a new joint supplement against a placebo and another supplement. It will start in July 2014 and finish in July 2015, enrolling subjects at random.
Who is the study for?
Adults aged 18-90 with moderate knee osteoarthritis, able to walk unassisted and have a specific score on the Lequesne's Functional Index can join. Excluded are those with systemic inflammatory conditions, hormone therapy users, recent recipients of corticosteroid injections in the knee, fish oil allergies, heavy drinkers, pregnant or breastfeeding women, and those taking certain supplements.
What is being tested?
The study is testing an anti-inflammatory product called PRN Joint Health Formula against a placebo and another combination product (PRN Flex Omega Benefits®). Participants will be randomly assigned to one of these treatments in equal numbers at each site.
What are the potential side effects?
Potential side effects may include allergic reactions for those sensitive to fish oil (in the active treatment groups), digestive issues due to supplement intake, and possible interactions with other medications or supplements not disclosed.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
My knee pain affects my daily activities significantly.
Select...
I have moderate knee arthritis.
Select...
I can walk 50 feet by myself.
Select...
I am between 18 and 90 years old.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I have a condition like inflammatory bowel disease, psoriasis, or eczema.
Select...
I am currently on hormone replacement therapy.
Select...
I do not have allergies to NSAIDs, liver or kidney issues, history of stomach ulcers or bleeding, heart failure, high blood pressure, cancer, or high potassium levels.
Select...
I do not have significant blood, clotting, or nerve disorders.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 12 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 weeks
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Human Inflammation Multi analyte profile (MAP) v1.0 in Synovial fluid and blood
Trial Design
3Treatment groups
Experimental Treatment
Active Control
Placebo Group
Group I: Joint Health ProductExperimental Treatment1 Intervention
natural dietary supplement
Group II: Combination with Omega-3Active Control1 Intervention
combination with omega-3 fish oil
Group III: PlaceboPlacebo Group1 Intervention
vegetable oil placebo
Find a Location
Who is running the clinical trial?
Physician Recommended NutriceuticalsLead Sponsor
4 Previous Clinical Trials
322 Total Patients Enrolled
Rothman Institute OrthopedicsUNKNOWN
Javad Parvizi, MDPrincipal InvestigatorRothman Institute
2 Previous Clinical Trials
130 Total Patients Enrolled
1 Trials studying Osteoarthritis
80 Patients Enrolled for Osteoarthritis
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am between 18 and 90 years old.I have a condition like inflammatory bowel disease, psoriasis, or eczema.I have inflammatory arthritis in my knee, like rheumatoid arthritis or ankylosing spondylitis.I am currently on hormone replacement therapy.I have moderate knee arthritis as defined by a specific grading system.I have not had joint injections in the last 3 weeks.I have moderate to severe arthritis in my knee.I do not have significant blood, clotting, or nerve disorders.I am taking vitamins/supplements without changing the dose or brand, and they don't contain the same ingredients as in the PRN Joint health formula.I have moderate knee arthritis.I have arthritis in both knees but only one will be part of the study.I do not have allergies to NSAIDs, liver or kidney issues, history of stomach ulcers or bleeding, heart failure, high blood pressure, cancer, or high potassium levels.My knee pain affects my daily activities significantly.I have moderate knee arthritis with symptoms.I can walk 50 feet by myself.I can walk 50 feet by myself.I am scheduled for knee surgery within the next three months.I am between 18 and 90 years old.
Research Study Groups:
This trial has the following groups:- Group 1: Joint Health Product
- Group 2: Placebo
- Group 3: Combination with Omega-3
Awards:
This trial has 0 awards, including:Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Osteoarthritis Patient Testimony for trial: Trial Name: NCT02333084 — Phase 2 & 3